Engineer Noimot Salako-Oyedele holds a Masters degree in Public Health Engineering from the Imperial College of Science & Technology London, UK, and a Bachelor of Science degree in Civil Engineering from the University of Lagos.

As a team leader with over 30 years of proven records of experience, she is a strategist and astute manager of resources and has been on the Board of several companies in Nigeria and the United Kingdom. In 2015, she became the Acting Managing Director of Grenadines Homes Limited, a position she held till she ventured into partisan-politics and emerged as the Ogun State Deputy Governor.

Mr Ighodalo is the co-founding partner of Banwo & Ighodalo, a leading full-service law firm in Nigeria. He specializes in advising major corporations on Corporate Finance, Capital Markets, Energy & Natural Resources, Mergers & Acquisitions, Banking & Securitization and Project Finance. He is the chairman sterling Bank, Director, Chairman NESG - Nigerian Economic Summit Group.

Rasheed Gbadegesin, MBBS, MD is the Wilburt C. Davison Distinguished Professor of Paediatrics,  Associate Dean for Physician Scientist Development and Co-Director Duke CTSA-KL2 Program.

Dr Gbadegesin's research is focused on understanding the critical pathways that are involved in the pathogenesis of nephrotic syndrome and in congenital malformations of the kidney and the urinary tract.

He and his group have established a phenotypic and biorepository data base for more than 600 children with hereditary and sporadic nephrotic syndrome. In the past two years they have identified two novel genes for hereditary nephrotic syndrome and vesicoureteric reflux (VUR).

They have also identified a disease risk allele for childhood onset steroid sensitive nephrotic syndrome (SSNS). 

CHARLES REDDING has served as CEO and President of MedShare International, Inc. since 2014. From 2012 until 2014 he served as Chief Operating Officer, leading efforts to expand to a third region in the Northeast with a Sorting and Collection Center in Secaucus, New Jersey.

Under Charles’ leadership MedShare has experienced record-breaking years of humanitarian aid shipments, programmatic interventions, fundraising and community outreach. His strategic shift from outputs and a relentless focus on measurable outcomes and impact are recognized as major contributors to the organization’s expanded success.

His leadership in responding to the 2014 Ebola Virus outbreak in West Africa and the 2020 COVID-19 pandemic garnered significant recognition and accolades. He was named Georgia Trend’s 2021 Notable Georgian.

Stuart is the Global Head of Patient Advocacy at Chiesi Rare Diseases where he is responsible for patient advocacy strategy and community engagement across the rare disease portfolio.

​

He has more than 20 years of global advocacy experience both in and outside of the biopharma industry. His most recent experiences were as the Global Director of Public Affairs & Patient Advocacy for the rare blood disorders business unit at Sanofi Genzyme and previously as the leader of Global Patient Advocacy at Bioverativ Therapeutics focusing on their pre-commercial rare disease pipeline.

​

Stuart is also the co-founder and Director of the Sanfilippo Research Foundation, a non-profit dedicated to research into Sanfilippo Syndrome/MPS III, a rare inherited lysosomal storage disorder, of which his son Benjamin was a sufferer.

​

He guided academic-based research from basic science to pre-clinical licensing and was instrumental in building a non-profit consortium that provided funding to launch a company bringing this foundation work to multiple phase I/II gene therapy clinical trials.

​

He participates in number of NGO/GOVT/Industry rare disease groups and associations on advisory boards or as a member.

Stuart holds a bachelor’s degree in Cognitive Science from the University of Rochester.

A Professor of Medicine/Consultant Gastroenterologist & Hepatologist, he studied Medicine at the College of Medicine, University of Ibadan from where he graduated MBBS in 1989. After the one year internship programme at the Obafemi Awolowo University Teaching Hospitals complex, Ile-Ife in 1990, he proceeded to the Nigerian Navy Medical Centre, Urhiapele, Sapele in the then Bendel state for the mandatory National Youth Service, which he completed Delta State in 1992.

​

In 2002, he obtained a postgraduate certificate in Gastroenterology at the University of Tel-Aviv and the Chaim Sheba Medical Centre, Tel Hashomer, Israel to study advanced Gastroenterology/Hepatology as well as Gastrointestinal endoscopy. Professor Otegbayo completed a master’s degree in chemical Pathology and Immunology at the University of Ibadan in 2003 and was awarded the Fellowship of Recherche microbiologique pour le development for the laboratory work of his Ph. D at the Laboratoire de Sante, Institute of Immunology, Luxembourg in 2006. The Ph.D was awarded by the University of Ibadan in 2011. He also obtained the prestigious Fellowship of the American College of Gastroenterology (FACG), United States of America, the first in Nigeria, in 2009.

​

Prof. Otegbayo is the Interim Director, West African Centre for Infectious Disease Surveillance (WACIDS), African Union, Scientific, Technical and Research Commission (AU-STRC), and a member of the Focus Scientific Research Corporation “Hepatitis in Africa” Programme. His research interest is in microbial pathobiology of the gut and liver, especially viral hepatitis, Helicobacter pylori and Liver cancer, as well as curriculum development and medical education.

Dr Egbe Dawodu MBBS, MBA, MSc, MRCP is a founding Partner of the Anadach Group where she leads the Management Consulting and Clinical Service Improvement Product Lines. Her primary areas of focus have been hospital restructuring, due diligence evaluation, strategic planning and implementation.

Dr Osifo-Dawodu was previously an Adviser at the Innovation Practice at the World Bank Institute. Prior to joining the innovation practice, as one of the core members of the Nelson Mandela Institution's management team she helped develop and start the African University of Science and Technology, Abuja - a Pan African University with Graduate Students from over 20 African Countries.

​

She previously managed the Human Development Group at the World Bank Institute where she was responsible for the World Bank's capacity building programs in health, education and social protection. She has a relatively unusual background in the World Bank Group having led and worked on both health policy dialogue and projects with Governments at the World Bank and with the private health sector projects at the International Finance Corporation.

Dr. Obasanjo received a Doctor of Veterinary Medicine degree from the University of Ibadan, Nigeria in 1988 and a Master's in Preventive Veterinary Medicine from University of California at Davis in 1992. She proceeded to Cornell University and completed her PhD in Epidemiology in 1995. She was a Post-Doctoral Fellow at Wake Forest University for 2 years and then worked as a Statistician and Project Manager in clinical research for pharmaceutical drug development for FDA approval. She was appointed Commissioner for Health in Ogun State of Nigeria in 2003 and elected to the Nigerian Senate in 2007, where she was the Chair of the Health Committee. In 2011, she became an Advanced Leadership Fellow at Harvard University and explored the issues of governance, leadership and public health. She has given presentations around the world and was a Visiting Professor at Virginia Military Institute in the 2016/2017 academic year and also taught Applied Public Health to graduate students at Mary Baldwin University in the spring semester.

Professor Ofili obtained a bachelor’s degree (MBBS) in Medicine and Surgery (June, 1987) from University of Ibadan, Nigeria.

​

She holds a Fellowship (FMCPH; 2000), MD (Doctor of Medicine; December 2020) degree of the National Postgraduate Medical College of Nigeria, and a Fellowship of West African College of Physicians (FWACP; April 1998).

​

Her teaching and research career started in 1998. She has supervised over fifty-five (55) postgraduate dissertations, has over eighty (80) journal articles, several conference papers and seminar presentations. She has served as external examiner to several universities and is the Chairman of Ethics and Research Committee, UBTH and Chief Examiner, Faculty of Community Health, West African College of Physicians among others.

​

Professor Kuliya-Gwarzo obtained a bachelor’s degree (MBBS) in Medicine and Surgery (1990) from University of Maiduguri, Bornu State, Nigeria.

She holds an MSc from the University of Bristol, United Kingdom in Transfusion and Transplant Science (2009), after qualifying for her FMCPath in Haematology and Blood Transfusion (2002).

​

Aisha is a prolific author of scientific publications on SCD as a major research interest and the use of blood in mitigating the complications of the disease. She is a member of about a dozen professional bodies across the world.

​

Amongst numerous other distinctions, she was honoured by StandTall Africa Initiative Award for Fatima Batul outstanding Women in Africa in 2021

​

Ibraheem (Ib) is responsible for external innovation for Ethicon, $9B surgery business of Johnson & Johnson MedTech business. Ib was previously the New Ventures leaders at Johnson & Johnson Innovation. From 2010 to 2013, Ib was a Research Fellow at Global Surgery Group of Johnson & Johnson, where he was responsible for external and front-end innovations and intellectual property for Ethicon Biosurgery. From 2006 to 2010, he was the Director of Applied Research & New Technology Assessment of novel biomaterials. Prior to that, he was the Chief Scientist of Closure Medical Corp (acquired by Johnson & Johnson in 2005. He currently serves as an Adjunct Professor of Biomedical Engineering at Drexel University.

Ib has received multiple awards and distinctions and he serves as a board member and on advisory roles of several organisations.

Wendy is a family medicine physician, she is a graduate of the College of Medicine at the University of Ibadan, Class of ’87.

​

Currently, she is an Independent Healthcare Consultant in clinical and administrative roles, in Nigeria and the United States of America.

​

She joins the Foundation bringing with her decades of experience and knowledge in the public and private health sector especially with her role as the former Special Adviser on Public Health to the Lagos State Governor, now the Hon. Min. for Works and Housing, Mr. Babatunde Raji Fashola during his 2011 to 2015 tenure.

In her spare time, she enjoys listening to music, dancing, creating beaded jewellery and jewellery wire works.

Jide Adetunji is a chartered management accountant with expertise in advising c-suite executives of major corporations and SMEs on business strategic & planning, risk management and business intelligence. His career spans two and a half decades consulting in various industry sectors across Europe, USA, and Australia.

He is a co- founder of Amoke Foundation, a charitable organisation focused on sickle cell anaemia at the grassroot level in sub-Saharan Africa.

Jide is an ‘Amokelian’